Users with any claims-based rhabdomyolysis diagnosis during baseline were excluded. For patients with multiple hospitalizations, the outcome date was defined by the first hospitalization with ...
Monitor liver aminotransferases, myopathy, and rhabdomyolysis. Discontinue if signs/symptoms of severe skin or hypersensitivity reactions develop. Hepatic impairment: Isentress HD not recommended.
Monitor liver aminotransferases, myopathy, and rhabdomyolysis. Discontinue if signs/symptoms of severe skin or hypersensitivity reactions develop. Hepatic impairment: Isentress HD not recommended.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback